Strategic Partnership PRA Health Sciences is now part of ICON plc, creating a combined platform that can offer broader healthcare intelligence and clinical research services. This presents cross-sell opportunities to introduce joint offerings that leverage ICON’s AI and Orbis capabilities to existing PRA/PRA-like clients and vice versa.

AI Capabilities ICON’s Orbis platform and recent collaboration with Anthropic highlight a strong AI-driven approach across the clinical trial lifecycle. Position these capabilities to prospects seeking accelerated trials, improved governance, and data-driven decision making, with emphasis on scalable, compliant AI governance.

Sustainability & ESG ICON earned Platinum EcoVadis status and improved CDP Climate Change scores, plus recognition as a TIME World’s Most Sustainable Company. Use these credentials to engage with pharmas and biotechs prioritizing ESG-aligned vendors, offering sustainability reporting and responsible sourcing as a differentiator.

Global scale With thousands of employees and multi-billion revenue indicators, ICON–PRA combines extensive global reach with advanced clinical operations. Target large sponsors needing global trial execution, diverse patient access, and seamless site network management across regions.

Strategic Partnerships Recent UNICEF collaborations and multi-year AI initiatives signal a pattern of establishing mission-aligned relationships. Leverage this to position the company for opportunities in humanitarian health programs, public health initiatives, and payer-agnostic research collaborations requiring robust AI-enabled operations.